Recombinant VEGF (Bevacizumab Biosimilar) antibody
The Humanized Chimeric anti-VEGF (Bevacizumab Biosimilar) antibody is suitable to detect VEGF (Bevacizumab Biosimilar) in samples from Human.
Catalog No. ABIN7597555
$401.14
Plus shipping costs $50.00, if applicable $20.00 dry ice
Shipping to:
United States
Delivery in 12 to 15 Business Days
Quick Overview for Recombinant VEGF (Bevacizumab Biosimilar) antibody (ABIN7597555)
Target
VEGF (Bevacizumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Humanized
Clonality
Chimeric
Conjugate
This VEGF (Bevacizumab Biosimilar) antibody is un-conjugated
Application
Please inquire
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Research Grade Bevacizumab Biosimilar Antibody
-
Specificity
- Vascular endothelial growth factor A, VPF, VEGFA, VEGF, Vascular permeability factor, VEGF-A
-
Purification
- Protein A or G purified from cell culture supernatant.
-
Purity
- >95 % by SDS-PAGE.
-
Isotype
- IgG1 kappa
-
-
anti-VEGF (Bevacizumab Biosimilar) antibody
Research Grade Reactivity: Human ELISA Host: Humanized Monoclonal unconjugated Recombinant Antibody
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
Expiry Date
- 12 months
-
-
- VEGF (Bevacizumab Biosimilar)
-
Alternative Name
- Bevacizumab Biosimilar
-
Target Type
- Biosimilar
-
Background
- Vascular endothelial growth factor A, VPF, VEGFA, VEGF, Vascular permeability factor, VEGF-A
-
UniProt
- P15692
-
CAS-No
- 216974-75-3
Target
-
You are here:
